Andean Precious Metals (CVE:APM) Trading Down 9.6% – Time to Sell?

Andean Precious Metals Corp. (CVE:APM)’s stock price was down 9.6% during trading on Tuesday . The stock traded as low as C$1.12 and last traded at C$1.13. Approximately 515,749 shares were traded during mid-day trading, an increase of 167% from the average daily volume of 193,385 shares. The stock had previously closed at C$1.25.

Analysts Set New Price Targets

Separately, Desjardins upgraded Andean Precious Metals to a “moderate buy” rating in a report on Thursday, October 31st.

Andean Precious Metals Stock Performance

The stock has a market capitalization of C$170.27 million, a price-to-earnings ratio of 3.00 and a beta of 1.22. The business’s 50 day simple moving average is C$1.46 and its 200-day simple moving average is C$1.25.

Insiders Place Their Bets

In other news, insider 2176423 Ontario Ltd. bought 213,800 shares of the firm’s stock in a transaction that occurred on Wednesday, October 2nd. The stock was acquired at an average price of C$1.38 per share, with a total value of C$294,530.88. In the last quarter, insiders acquired 306,200 shares of company stock worth $432,953. 69.37% of the stock is owned by company insiders.

About Andean Precious Metals

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.